Skip to main content

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

Media Contact: Amy Hytowitz, 949-250-5070

Investor Contact: Mark Wilterding, 949-250-6826

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.14
+1.58 (0.76%)
AAPL  273.69
+1.55 (0.57%)
AMD  213.34
-0.50 (-0.23%)
BAC  51.28
+0.87 (1.73%)
GOOG  310.73
-0.19 (-0.06%)
META  648.84
+9.54 (1.49%)
MSFT  399.21
+10.21 (2.63%)
NVDA  195.83
+2.98 (1.55%)
ORCL  150.59
+4.46 (3.05%)
TSLA  414.69
+5.31 (1.30%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.